Orthobond
Orthobond Corp
Orthobond is an antimicrobial technology company that has developed proprietary antimicrobial nanosurfaces, with broad applications in the medical device industry and more such as commercial, industrial, automotive, and beyond.
orthobond.com · Monmouth Junction, NJ
Funding event
The round itself, as filedInferred stageSeries A
Sold of offered$8.3M of $10.0M
Filed2026-09-01
Days since filing32
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-08-24
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- David NicholsExecutive Officer · Director
- Khalil BarrageDirector
- Frank CammisaDirector
- David HelfetDirector
- Anna Paulina LutzDirector
- Peter ScaturroDirector
- Lisa D'UrsoDirector
- Kenneth GallDirector
- Shailesh MaingiDirector
- Pritam MishraDirector
- Eric MajorDirector
- Greg ColeDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged83.5% sold1.3 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-210
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-02, against 71 in the 28 days before.